One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...
PsyPost on MSN
Brain volume in bipolar disorder increases during depression and shrinks during remission
A longitudinal neuroimaging study comparing individuals with bipolar disorder and healthy participants found that bipolar ...
It is well-proven that cannabis use is associated with an increased risk of schizophrenia and heavy use of high-THC marijuana is associated with four times the normal rate of schizophrenia (see my ...
Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...
Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...
Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...
As marijuana use among teens has grown in the past decade, researchers have been trying to better understand the health risks of the drug. Now, a new longitudinal study finds that cannabis use among ...
A recent Nutrients journal study reviews the potential beneficial effects of the ketogenic diet (KD) on anxiety, depression, stress, schizophrenia, and bipolar disorder. Study: The Potential Effects ...
Whether you live with bipolar disorder or major depressive disorder, you experience periods of depression. This can make it hard to tell them apart. But the bi-in bipolar means “two” because it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results